Exhibit 10.3
CONFIDENTIAL
Page 1 of 7
June 16, 2008
EMPLOYMENT AGREEMENT
This Agreement, made and entered
into effective the 16 th of June 2008 by and between
Chad Ruwe, an individual residing at 5220 Oaklawn Avenue, Edina, MN
55424 (“Employee”), and BioDrain Medical Incorporated,
699 Minnetonka Highlands Lane, Orono, MN 55356-9728, a Minnesota
corporation (“Company”).
WITNESSETH:
WHEREAS,
the Company desires to employ the
Employee to render services for the Company as its Executive Vice
President of Operations on the terms and conditions hereinafter set
forth, and the Employee desires to be employed by the Company on
such terms and conditions;
NOW,
THEREFORE, in
consideration of the promises and of the mutual covenants and
agreements contained herein, the parties hereby agree as
follows:
|
|
|
|
|
|
|
1.
|
Employment.
Upon execution of an investment in
the Company by the Employee of $200,000, the Company agrees to
employ the Employee for a period of two (2) years from the date of
this Agreement: unless Employee violates the terms set forth in
Paragraph 7: Termination by the Company for Cause or the Employee
voluntarily resigns. The term is automatically renewable annually
except by action of the President or the Board of
Directors
|
|
|
|
|
|
|
2.
|
Duties.
The Employee will hold the title of
Executive Vice President of Operations and shall report to the
President/CEO of the Company. The general scope of the
Employee’s duties shall include: to oversee and manage all
areas relating to interaction with the FDA, all manufacturing
functions and capabilities, all R&D functions, all operational
aspects relating to Intellectual Property, all logistical
considerations for the Company, including but not limited to
service and installation of the FMS (Fluid Management System) unit
and distribution of cleaning fluid, overseeing all related vendors
and consultants, and other Operations-related duties and functions
that may arise from time to time.
|
|
|
|
|
|
|
|
The Employee’s duties may
be modified from time to time by mutual agreement between the
Employee and the President/CEO as they deem to be in the best
interest of the Company, provided that the Employee’s duties
shall be commensurate with those of a senior executive of the
Company.
|
|
|
|
|
|
3.
|
Extent of Services.
The Employee shall devote his full
attention, energy and skills to the business of the Company and use
his best efforts to fully and competently perform the duties of his
office.
|
|
|
|
|
|
|
4.
|
Compensation.
|
|
|
|
|
|
|
|
a.
|
Base Salary.
$135,000 per year. Initial payment
will be monthly and will be according to the Company’s salary
schedule. Employee will have an informal performance review in six
(6) months and will receive annual salary reviews and potential
increases, based on Employee’s performance.
|
CONFIDENTIAL
Page 2 of 7
|
|
|
|
|
|
|
|
|
b.
|
Bonus. The Employee will receive a one-time signing
bonus of $15,000 upon execution of this Agreement in recognition of
his investment in the Company. The Employee will be eligible for
participation in the Company’s bonus plan when completed and
approved by the Board of Directors and the Compensation Committee.
Bonus will be paid at the first payroll period after
employment.
|
|
|
|
|
|
|
|
|
c.
|
Stock Options.
The Employee will receive total
stock options to purchase 250,000 shares of the Company’s
common stock at $.35 per share. This will be governed by a Company
Stock Option Plan to be established by the Company in a timely
manner upon hiring of the Employee. Vesting of the 250,000 options
will be as follows: 50,000 shares upon execution of this Agreement;
the balance in achievement of the following specific
milestones:
|
|
|
|
|
|
|
|
|
|
•
|
An additional 50,000 shares to
vest upon submission of the 510(k) to the FDA for approval of the
FMS unit,
|
|
|
|
|
|
|
|
|
|
|
•
|
An additional 50,000 shares to
vest upon approval of the 510(k) by the FDA,
|
|
|
|
|
|
|
|
|
|
|
•
|
An additional 50,000 shares to
vest upon sale of the first commercial-ready FMS unit,
|
|
|
|
|
|
|
|
|
|
|
•
|
An additional 50,000 shares to
vest upon sale of the 50 th commercial-ready FMS
unit.
|
|
|
|
|
|
|
|
|
|
The total of these options,
assuming all milestones are achieved, will be 250,000, as described
above.
|
|
|
|
|
|
|
|
d.
|
Executive
Compensation. The
Employee will be eligible for executive compensation such as bonus,
stock, stock options, deferred compensation, life insurance, etc.,
as approved by the Board of Directors and the Compensation
Committee when such executive compensation plan is
completed
|
|
|
|
|
|
|
|
5.
|
Additional
Benefits.
|
|
|
|
|
|
|
|
a.
|
Automobile.
The Company shall reimburse the
Employee for deductible automobile mileage or auto allowance
according to its Expense Reporting Procedures.
|
|
|
|
|
|
|
|
|
b.
|
Business Expense.
The Company will reimburse the
Employee for all reasonable, deductible and substantiated business
expenses per its Expense Reporting Procedures. This includes, but
is not limited to such expenses as telephone, cell phone, home
office, business meetings, etc.
|
|
|
|
|
|
|
|
|
c.
|
Benefits.
The Employee will be eligible for
the Company’s benefits package and executive benefits listed
in Paragraph 4.d. which will be implemented as funds become
available and upon development and approval by the Compensation
Committee. In lieu of, and until a company-sponsored medical
benefits program is installed, Employee will receive a monthly
amount of $1,000.
|
|
|
|
|
|
|
|
|
d.
|
Vacation.
The Employee will receive a minimum
of three (3) weeks’ vacation per year or as per the executive
vacation plan when written, whichever is greater.
|
CONFIDENTIAL
Page 3 of 7
|
|
|
|
|
|
|
|
e.
|
Education.
The Company will support the
Employee in his pursuit of continuing education provided sufficient
cash flows support tuition reimbursement and he meets the
conditions and terms of the tuition reimbursement guidelines as
outlined in the Employee Manual when written.
|
|
|
|
|
|
|
|
5.
|
Board of Directors
Membership. The Employee,
as soon as Myron Schuster is paid and removed from the Board, which
action is being pursued as of this writing, will become a member of
the Board of Directors of the Company. In any event, regardless of
the handling of the situation with Mr. Schuster, Employee shall
become a Board member within 30 days of this date.
|
|
|
|
|
|
|
|
6.
|
Non-Compete.
Throughout the period of
Employee’s employment with the Company, and thereafter for a
period of one (1) year, Employee shall not, for any reason
whatsoever, directly or indirectly, plan, organize, advise, own,
manage, operate, control, be employed by, participate in or be
connected in any manner with the ownership, management, operation
or control of any business of the following type: the development,
marketing and sales of medical devises dedicated or designed to
safely manage and dispose of contaminated fluids generated in the
operating room and other similar medical locations. For purposes of
this Agreement, indirect competition shall be deemed to include any
activity by Employee in aid of a competing Business, including but
not limited to, being a partner, shareholder, officer, director,
member, owner, manager, governor, agent, employee, advisor,
consultant or independent contractor of any competing
Business.
|
|
|
|
|
|
|
|
7.
|
Intellectual
Property. Employee agrees
that all right, title and interest of every kind and nature
whatsoever, whether now known or unknown, in and to any
“Intellectual Property,” defined to include, but not be
limited to, any patent rights, trademarks, copyrights, ideas,
creations and properties invented, created, written, developed,
furnished, produced or disclosed by Employee in the course of
rendering his/her services to Company (both before the execution of
this Agreement and thereafter) shall, as between the parties, be
and remain the sole and exclusive property of Company for any and
all purposes and uses whatsoever, and Employee shall have no right,
title or interest of any kind or nature therein or thereto, or in
and to any results and proceeds therefrom. Employee agrees to
assign, and hereby expressly and irrevocably assigns, to Company
all worldwide rights, title and interest, in perpetuity, in respect
of any and all rights Employee may have or acquire in the
Intellectual Property. The assignment of the rights as above shall
not lapse if Company has not exercised its rights under the
assignment for any period of time or in any jurisdiction or
territory. Pursuant to Section 181.78 of the Minnesota Statutes,
the preceding sentence does not apply to an invention for which no
equipme
|
|